Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Prevention”

186 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 186 results

Testing effectiveness (Phase 2)Study completedNCT02313155
What this trial is testing

Phase 1/2 Study of TAK-850 Subcutaneous Injection in Healthy Adults

Who this might be right for
Influenza Infection
Takeda 110
Early research (Phase 1)Study completedNCT00136331
What this trial is testing

Study of a Pandemic Influenza Vaccine

Who this might be right for
Influenza
Seqirus 400
Large-scale testing (Phase 3)Study completedNCT03189537
What this trial is testing

Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections

Who this might be right for
Influenza, HumanAcute Respiratory InfectionCommon Cold+2 more
Valenta Pharm JSC 400
Early research (Phase 1)Study completedNCT01302990
What this trial is testing

Safety, Tolerability and Immunogenicity of a Plant-Made H1 VLP Influenza Vaccine in Adults

Who this might be right for
Flu
Medicago 100
Not applicableStudy completedNCT00446628
What this trial is testing

Project to Investigate Ways to Reduce the Spread of Influenza in Schools and Households With Children

Who this might be right for
Influenza
Kiren Mitruka 3,360
Early research (Phase 1)Study completedNCT00309647
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of Pandemic Monovalent (H5N1) Influenza Vaccines (Whole Virus Formulation) in Adults 18 and 60 Years of Age

Who this might be right for
Influenza
GlaxoSmithKline 400
Testing effectiveness (Phase 2)Study completedNCT05507567
What this trial is testing

Safety, Tolerability and Prophylactic Antiviral Activity of Neumifil Against Influenza Via a Human Viral Challenge Model

Who this might be right for
Influenza Viral Infections
Pneumagen Ltd. 104
Large-scale testing (Phase 3)Study completedNCT00784784
What this trial is testing

Zanamivir Versus Trivalent Split Virus Influenza Vaccine

Who this might be right for
Influenza
Mount Sinai Hospital, Canada 64
Not applicableStudy completedNCT01390792
What this trial is testing

Special Drug Use Investigation for Relenza® (Zanamivir) (Prophylaxis)

Who this might be right for
Influenza, Human
GlaxoSmithKline 622
Early research (Phase 1)Study completedNCT05970744
What this trial is testing

Evaluation of RSV/Flu-01E Vaccine for the Prevention of RSV Infection in Volunteers Aged 18 to 59 Years and Over 60 Years

Who this might be right for
Respiratory Syncytial Virus Infections
Tatyana Zubkova 60
Post-approval studies (Phase 4)Study completedNCT03378479
What this trial is testing

Posaconazole for the Prevention of Influenza-associated Aspergillosis in Critically Ill Patients

Who this might be right for
Aspergillosis; Pulmonary, Invasive (Etiology)
Universitaire Ziekenhuizen KU Leuven 88
Early research (Phase 1)Study completedNCT00722774
What this trial is testing

Safety and Immune Response to Recombinant Live-Attenuated Influenza H2N2 Virus Vaccine

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 22
Not applicableUnknownNCT04297462
What this trial is testing

Different Regimens in Influenza Postexposure Chemoprophylaxis in Children

Who this might be right for
InfluenzaExposurePrevention
Centre of Postgraduate Medical Education 50
Testing effectiveness (Phase 2)Study completedNCT00363077
What this trial is testing

Study to Evaluate the Immunogenicity and the Safety of an Adjuvanted Influenza Vaccine Candidate

Who this might be right for
Influenza
GlaxoSmithKline 150
Post-approval studies (Phase 4)UnknownNCT01053377
What this trial is testing

A Randomised Controlled Trial on the Effect of Post-exposure Oseltamivir Prophylaxis on Influenza Transmission in Nursing Homes

Who this might be right for
Influenza
National Institute for Public Health and the Environment (RIVM) 900
Early research (Phase 1)Study completedNCT01995695
What this trial is testing

Safety and Immunogenicity of a Live Attenuated H7N9 Influenza Virus Vaccine in Healthy Adults

Who this might be right for
Influenza A Virus, H7N9 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Study completedNCT00895947
What this trial is testing

Interferon Alpha Lozenges in the Prevention of Winter Colds and Flu

Who this might be right for
Upper Respiratory Tract Infections
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. 200
Not applicableStudy completedNCT01286142
What this trial is testing

Oseltamivir Infant Influenza Safety Study

Who this might be right for
Influenza, Human
Charite University, Berlin, Germany 900
Large-scale testing (Phase 3)Looking for participantsNCT07159763
What this trial is testing

Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza

Who this might be right for
Influenza
Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 7,500
Early research (Phase 1)UnknownNCT05056519
What this trial is testing

The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine

Who this might be right for
Influenza Prevention
Changchun BCHT Biotechnology Co. 160
Load More Results